Patents by Inventor James Storey

James Storey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant FIV glycoprotein 160 and P24 gag protein
    Patent number: 6228608
    Abstract: Feline immunodeficiency virus antigens from gp160 envelope protein, gp120 envelope protein and p24 gag protein, useful for the diagnosis, treatment, and prevention of FIV. The invention may also be used to purify FIV.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: May 8, 2001
    Assignee: Aquila Biopharmaceuticals, Inc.
    Inventors: Eli Young, Deborah Davis, James Storey, Gerald Beltz
  • Characterization of granulocytic ehrlichia and methods of use
    Patent number: 6204252
    Abstract: The present invention relates, in general, to granulocytic ehrlichia (GE) proteins. In particular, the present invention relates to nucleic acid molecules coding for GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins; purified GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding GE S2, S7, S22, S23, C6.1, C6.2, S11, E8, E46#1, and E46#2 proteins; a method of detecting nucleic acids encoding GE S2, S7, S22, S23, C6.1, C6.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: March 20, 2001
    Assignee: Aquila Biopharmaceuticals, Inc.
    Inventors: Cheryl Murphy, James Storey, Gerald A. Beltz, Richard T. Coughlin